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Abstract
Objective:  To  study  bone  mineral  density  (BMD)  in  adolescent  females  according  to  ﬁve  groups
of chronological  age  (CA),  bone  age  (BA),  and  breast  development  stage  (B),  and  to  correlate
these  parameters  with  plasma  bone  biomarkers  (BB).
Methods:  This  was  a  cross-sectional  study  performed  in  101  healthy  adolescent  females
between 10  and  20  years  old.  The  study  variables  were:  weight,  height,  body  mass  index  (BMI),
CA,  B,  BA,  calcium  intake,  BMD,  and  BB.  Osteocalcin  (OC),  bone  alkaline  phosphatase  (BAP),
and  C-terminal  telopeptide  (S-CTx)  were  evaluated  for  BB.  BMD  was  measured  using  dual  energyOsteoporosis;
Growth;
Bone  health
X-ray  absorptiometry  (DXA).
Results: BMD  in  lumbar  spine,  proximal  femur,  and  total  body  increased  with  age,  and  the
respective observed  averages  were:  in  CA1  (10  years  old),  0.631,  0.692,  0.798  g/cm2;  in  CA2
(11  to  12  years  old),  0.698,  0.763,  0.840  g/cm2;  in  CA3  (13  to  14  years  old),  0.865,  0.889,
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0.972  g/cm2;  in  CA4  (15  to  16  years  old),  0.902,  0.922,  1.013  g/cm2;  and  in  CA5  (17  to  19  years
old),  0.944,  0.929,  1.35  g/cm2.  These  results  showed  signiﬁcant  differences  between  13  and  14
years  of  age  (CA3)  or  when  girls  reached  the  B3  stage  (0.709,  0.832,  0.867  g/cm2).  The  highest
median  concentrations  of  BB  were  between  10  and  12  years  of  age  when  adolescents  were  in
the  B2--B3  (p  <  0.001).  Median  BB  concentrations  decreased  in  advanced  BA  and  B.
Conclusions:  BB  concentrations  were  positively  correlated  with  the  peak  height  velocity  and
negatively correlated  with  BMD  in  the  study  sites.  Increased  BMD  and  BB  concentrations  were
observed  in  B3.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
PALAVRAS-CHAVE
Adolescentes;
Densidade  mineral
óssea;
Mineralizac¸ão  óssea;
Remodelac¸ão  óssea;
Reabsorc¸ão óssea;
Osteocalcina;
Osteoporose;
Crescimento;
Saúde óssea
Relac¸ão  entre  as  idades  cronológica  e óssea  e  o  estágio  puberal  das  mamas  com  os
biomarcadores  ósseos  e  a  densidade  mineral  óssea  em  adolescentes
Resumo
Objetivo:  Avaliar  a  densidade  mineral  óssea  (DMO)  em  adolescentes  do  sexo  feminino  de
acordo com  a  idade  cronológica  (IC),  idade  óssea  (IO)  e  desenvolvimento  das  mamas  (M)  e
suas  correlac¸ões  com  biomarcadores  de  remodelac¸ão  óssea  em  plasma  (BO).
Métodos: Este  foi  um  estudo  transversal  prospectivo  feito  em  101  adolescentes  saudáveis  do
sexo  feminino  com  idade  entre  10  e  20  anos.  As  variáveis  estudadas  foram:  peso,  altura,  índice
de  massa  corpórea  (IMC),  IC,  IO,  M,  ingestão  de  cálcio,  DMO  e  BO.  A  osteocalcina  (OC),  fos-
fatase  alcalina  óssea  (BAP)  e  o  telopeptídeo  C  terminal  (S-CTx)  foram  os  biomarcadores  de
remodelac¸ão  óssea  avaliados.  A  DMO  foi  obtida  por  absorciometria  de  raios-X  de  dupla  energia
(DXA).
Resultados:  A  DMO  de  coluna  lombar,  fêmur  proximal  e  corpo  total  aumentou  com  a  idade,
e as  respectivas  médias  observadas  foram:  IC1  =  0,631,  0.692,  0,798  g/cm2;  IC2,  0,698,  0,763,
0,840  g/cm2;  IC3,  0,865,  0,889,  0,972  g/cm2;  IC4,  0,902,  0,922,  1,013  g/cm2;  e  IC5,  0,944,
0,929,  1,35  g/cm2.  Observou-se  diferenc¸a signiﬁcativa  entre  13  e  14  anos  (IC3)  ou  quando  as
meninas  estavam  em  M3  (0,709,  0,832,  0,867  g/cm2).  Os  valores  dos  BO  apresentaram  elevac¸ão
entre 10  e  12  anos  e  quando  as  adolescentes  estavam  em  M2--M3  (p  <  0,001).  Os  valores  das
medianas  dos  BO  diminuíram  com  o  avanc¸ar  da  IO  e  M.
Conclusões:  Os  BOs  mostraram  paralelismo  com  o  pico  de  velocidade  de  crescimento  e  demon-
straram correlac¸ão  negativa  com  a  DMO  no  sítios  avaliados.  O  aumento  da  DMO  e  dos  BOs  foi
observado  em  M3.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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The  skeleton  was  traditionally  known  as  a  passive  organ;
its major  function  was  considered  to  be  the  support  of  the
human body.  However,  it  is  currently  considered  a  mutable
organ that  participates  in  interactions  between  regulatory
and energetic  mechanisms  acting  in  conjunction  with  the
adipose tissue.1,2
Puberty  is  considered  an  important  time  of  substantial
bone growth,  and  therefore,  sensitive  to  external  inﬂuences
that have  strong  effects,  such  as  diet,  physical  exercise,
lifestyle, and  medications.3
Bone  metabolism  is  characterized  by  cycles  of  formation
and reabsorption,  and  the  balance  between  these  two  pro-
cesses changes  through  life.  During  infancy  and  adolescence,
bone formation  predominates  over  absorption;  in  adult  life,
4both processes  stabilize. Bone  remodeling  is  also  strongly
related to  variations  in  body  weight,5,6 including  changes  in
muscle mass  and  body  fat  content.  Thus,  the  mechanical
p
moad  imposed  on  the  skeletal  system  interferes  with  bone
ormation.
According to  Haeney  et  al.,7 peak  bone  mass  represents
he highest  bone  mass  value  or  maximum  quantity  of  bone
hat an  individual  attains  when  their  skeleton  is  totally
ineralized or  consolidated.  Currently,  it  is  not  precisely
stablished at  what  age  biological  or  chronological  peak
one mass  occurs;  there  is  evidence  that  it  occurs  at  the
nd of  adolescence.8
Bone  mass  deposition  begins  during  fetal  life  and  con-
inues during  infancy  and  adolescence,  stabilizing  at  the
eginning of  adulthood.  Understanding  and  evaluating  bone
ass  acquisition  in  a  population  of  adolescents  could
e a  determining  factor  in  the  prevention  of  osteope-
ia/osteoporosis, which  are  diseases  considered  publicBone  mineral  density  (BMD)  is  considered  an  important,
recise, and  statically  valid  measurement;  however,  BMD
easurements do  not  reﬂect  the  dynamic  changes  to  which
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one  tissue  has  undergone,  representing  only  one  moment
n an  evolving  condition.  To  overcome  this  limitation  and  to
mprove the  sensitivity  and  speciﬁcity  of  bone  mass  status
valuation, the  use  of  bone  biomarkers  (BBs)  has  been  sug-
ested to  improve  the  understanding  of  the  bone  remodeling
rocess.10--12
Important  serum  biomarkers  of  bone  formation  include:
) osteocalcin  (OC),  a  non-collagenous  protein  abun-
ant in  bone,  predominantly  synthesized  by  differentiated
steoblasts, and  considered  to  be  a  sensitive  biomarker  of
one synthesis  activity;  and  b)  bone  alkaline  phosphatase
BAP), an  ectoenzyme  or  speciﬁc  glycoprotein  found  on  the
urface of  osteoblasts,  with  an  important  function  in  bone
ineralization, and  considered  as  a  highly  sensitive  and  spe-
iﬁc  bone  formation  indicator.13 In  addition,  studies  have
uggested that  the  C-terminal  telopeptide  (S-CTx)  fragment,
 bone  reabsorption  marker,  is  a  good  marker  to  evaluate
one formation  processes  because  it  is  formed  when  colla-
en type  I  degradation  occurs.
Bone  remodeling  biomarkers  are  important  tools  for
nderstanding the  dynamics  of  bone  metabolism  and  add
nformation acquired  from  bone  densitometry.
Therefore,  this  was  the  ﬁrst  study  that  evaluated  bone
ineral density  (BMD)  in  Brazilian  adolescent  females
ccording to  chronological  age  (CA),  bone  age  (BA),  and
reast development  stage  (B),  correlating  this  parameter
ith bone  biomarkers  (BBs).
ethods
ealthy  white  adolescent  females  (non-African  or  non-Asian
escendants) between  10  and  20  incomplete  years  old  were
nvited to  participate  in  this  study.  The  volunteers  were  stu-
ents at  the  La  Salle  School  in  Botucatu,  São  Paulo  State,
razil and  Santa  Marcelina  School  in  Botucatu.  A  total  of
01 out  of  497  adolescent  female  students  in  the  studied
ge group,  were  included  in  the  study  and  participated  in
ll evaluations.
The study  was  approved  by  the  Botucatu  School  Medicine
thics Committee  --  UNESP.  Written  informed  consent  was
o-signed by  each  participant  (101)  and  their  parents  or
uardians.
The inclusion  criteria  comprised  weigh  between  the  10th
nd  90th percentiles  and  height  between  the  10th and  97.5th
ercentiles  for  each  age  group,14 adequate  body  mass  index
BMI) for  age,15 and  report  of  regular  and  daily  consumption
f dairy  products.
The exclusion  criteria  were:  history  of  prematurity  or  low
irth weight;  presence  of  diabetes  mellitus;  acute  or  chronic
nder-nourishment; congenital  or  acquired  bone  diseases;
astrointestinal diseases  accompanied  by  malabsorption;
istory of  nephropathy  with  or  without  chronic  renal  fail-
re; endocrinopathies;  early  or  late  puberty;  chronic  drug
onsumption; cystic  ﬁbrosis;  celiac  disease;  drug  use  that
egatively affected  bone  metabolism  (such  as  anticonvul-
ants and  antacids  with  aluminum);  more  than  2  h/week
hysical exercises,  since  excessive  physical  exercise  inter-
eres with  bone  mineralization;  use  of  contraceptives  24
onths prior  to  data  collection;  pregnancy  at  any  time;  and
bsence on  dates  assigned  for  the  study  data  collection.  The
ietary exclusion  criteria  were:  practices  of  an  exclusively
a
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egetarian  diet  and  high  ﬁber  diet;  caffeine  consumption;
oft drink  consumption  over  300  mL/day;  and  lack  of  dairy
roduct consumption.  These  rigorous  selection  criteria  were
pplied  in  order  to  minimize  interference  from  factors  that
ould affect  normal  bone  metabolism  during  puberty.
Based  on  the  inclusion  criteria,  eligible  adolescents
ere invited  to  have  their  weight  and  height  measured.
hose participants  ﬁtting  the  parameter  criteria  were  subse-
uently questioned  about  smoking  and  alcohol  consumption.
elected adolescents  were  invited  to  participate  in  the  study
s volunteers;  a  full  explanation  of  methods  and  procedures
as provided  to  participants  and  their  parents  or  guardians,
ncluding information  about  the  option  to  withdraw  from  the
tudy at  any  time.
Parents and  guardians  were  interviewed  and  participants
nderwent general  and  speciﬁc  physical  examinations  for
etection of  any  physical  abnormality  (adolescents  with
hronic congenital  infection  and  major  congenital  anoma-
ies) that  could  interfere  with  the  study  expected  results.
econdary sexual  characteristics  were  evaluated  and  results
ompared to  the  Tanner  criteria  for  breast  development  (B).
he average  age  at  menarche  in  the  group  of  participants
as similar  to  that  in  the  Brazilian  population  (12.2  years
ld).16 Skeletal  maturation  was  evaluated  by  the  determina-
ion of  bone  age  (BA)  according  to  the  GP  method  described
y Greulich  and  Pyle.17 The  parameters  of  chronological
ge (CA),  bone  age,  and  pubertal  stage  of  breasts  (B)  were
ivided into  ﬁve  groups.  Group  CA1  was  composed  of  females
ged 10  years;  CA2,  ages  11  and  12  years;  CA3,  ages  13  and
4 years;  CA4,  ages  15  and  16  years;  and  CA5,  ages  17  to
0 incomplete  years.  The  BA  groups  were  divided  into  BA1:
one age  (BA)  10  and  11  years;  BA2:  BA  12  and  13  years;
A3: BA  14  and  15  years;  BA  4:  BA  16  and  17  years;  and  BA
: BA  18  and  19  years.  Dietary  characterization  was  subse-
uently measured  using  a  non-consecutive  three-day  dietary
ecord.18 Questionnaires  for  centesimal  quantiﬁcation  of
ood were  applied  and  analyzed  using  a  computer  system
eveloped by  the  Department  of  Nutrition  at  the  School  of
ublic Health  from  the  Universidade  de  São  Paulo.19
Participants  who  completed  all  initial  steps  underwent
one mass  evaluation  using  a bone  densitometry  unit  and
y attenuation  of  dual  energy  X-ray  (DXA)  using  a  Hologic
DR 2000-Plus  (Hologic  Inc.,  Waltham,  MA,  USA)  according
o recommendations  of  the  International  Society  for  Clini-
al Densitometry.20 BMD  results  were  expressed  in  g/cm2.
easurements from  the  L1--L4  lumbar  spinal  region,  total
roximal femur  (including  the  femur  neck,  trochanteric,  and
ntertrochanteric regions),  Ward  area,  and  whole  body  den-
itometry were  taken.  The  amount  of  radiation  to  which
articipants were  exposed  was  considered  safe  and  not
armful to  their  current  and  future  life.20
lood  collection
lood  samples  were  collected  by  venous  puncture  and  cen-
rifuged by  15  minutes  at  1,500  g  for  serum  separation;
erum samples  were  stored  at  -70 ◦C  until  analyses  of  BAP
nd OC  and  carboxy  terminal  telopeptide  (S-CTx)  biomark-
rs. BAP  and  OC  were  measured  using  the  assay  (MetraTM
iosystems,  San  Diego,  CA,  USA),  with  intra-  and  inter-
ssay coefﬁcients  of  variation  of  8%  and  7.6%,  respectively.
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Table  1  Mean  and  standard  deviation  (SD)  of  nutritional  indicators  and  calcium  intake  according  to  chronological  age  (CA),
breast  development  stage  (B)  and  bone  age  groups  (BA).
Variables
Groups
Mean ±  SD  (n  total  =  101)
1  2  3  4  5
CA  (years)  (n  =  10)  (n  =  19)  (n  =  26)  (n  =  27)  (n  =  19)
Weight  (kg)  35.38  ±  7.2  42.90  ±  7.36  49.39  ±  7.02  52.33  ±  5.39  53.46  ±  7.62
Height  (m)  1.39  ±  0.07  1.50  ±  0.08  1.59  ±  0.05  1.60  ±  0.05  1.61  ±  0.04
BMI  (kg/m2) 17.64 ±  2.27 18.92  ±  2.59 19.26  ±  2.10  20.39  ±  1.77  20.44  ±  2.32
Calcium(mg/day)  652  ±  176 624  ±  271 533  ±  150 490  ±  153  532  ±  267
B  (n  =  5) (n  =  7) (n  11) (n =  37) (n  =  41)
Weight  (kg)  31.92  ±  4.7  39.18  ±  5.56  45.75  ±  7.98  50.31  ±  7.46  51.69  ±  6.04
Height  (m)  1.38  ±  0.05  1.43  ±  0.08  1.54  ±  0.09  1.60  ±  0.06  1.59  ±  0.05
BMI  (kg/m2)  16.24  ±  1.62  19.02  ±  2.84  18.81  ±  2.18  19.59  ±  2.18  20.31  ±  1.91
BA  (n  =  9) (n  =  14) (n  =  21)  (n  =  31)  (n  =  26)
Weight  (kg) 33.02  ±  4.4 45.20  ±  5.73 48.92  ±  6.68  53.46  ±  5.46  49.31  ±  12.6
Height  (m) 1.38 ±  0.05 1.52  ±  0.06 1.59  ±  0.05  1.60  ±  0.05  1.52  ±  0.37
BMI  (kg/m2) 16.99 ±  1.57 19.26  ±  2.58 19.24  ±  2.17 20.78  ±  1.73  18.88  ±  4.62
Note: ANOVA followed by Student-Newman Keuls.
BMI, body mass index.
Chronological age groups (years of age): CA1-10; CA2- 11- 12; CA3- 13-14; CA4- 15; CA5- 17-19.
Weight: CA1 < CA4 and CA5; CA2 < CA4 and CA5; p < 0.001
Height: CA1 < CA2, CA3, CA4 and CA5; CA2 < CA3, CA4 and CA5; p < 0.001
BMI: CA1 < CA4 and CA5; p < 0.001
Calcium: p = 0.407
Breast development stage groups (Tanner criteria)
Weight: B1 < B3, B4 and B5; p < 0.001
Height: B1 < B4 and B5; B2 < B4 and B5; p < 0.001
BMI: B1 < B5; B1 < B4; p < 0.001
Bone  agegroups (Greulich&Pyle):BA1- 10-11 years, BA2-12-13 years, BA3-14-15 years, BA4-16-17 years, BA5-18-19 years
Weight: BA1 < BA2, BA3, BA4 and BA5; BA2 < BA4 and BA5; p < 0.001
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sHeight:  BA1 < BA3, BA4 and BA5; BA2 < BA3, BA4 and BA5; p < 0.001
BMI:  BA1 < BA4 and BA5; p < 0.001
S-CTx  was  quantiﬁed  by  an  electrochemiluminescence  assay
using a  commercial  ß-Cross  Laps/serum  kit  (Roche  Diag-
nostic Corporation,  Indianapolis,  IN,  USA)  and  Elecsys  1010
(Roche Diagnostic  Corporation,  Indianapolis,  IN,  USA);  the
inter-assay coefﬁcient  of  variation  was  5%.
Statistical  analysis
Descriptive  statistics  data  were  expressed  as
mean ±  standard  deviation  using  analysis  of  variance
and the  Student-Newman-Keuls  method.  Kruskal  Wallis
analysis of  variance  and  the  Dunn  test  were  performed  for
comparisons between  bone  biomarkers  and  CA,  BA,  and  B
when the  Shapiro-Wilk  test  showed  non-normal  distribution
for these  data.  Spearman  coefﬁcients  of  correlation  were
calculated between  bone  biomarkers  and  BMD  results  in  the
evaluated locations  and  CA,  BA,  and  B.  Minimum  statistical
difference was  considered  at  5%.  Graphical  representation
included mean  DXA  values  and  median  bone  biomarker
concentrations in  relation  to  CA,  BA,  and  B.Results
Weight,  height,  BMI,  and  BMD,  measured  in  the  three  ana-
lyzed sites,  increased  with  age,  pubertal  stage  of  breasts,
p
s
(
tnd  bone  age  (Table  1,  and  Fig.  1  A-C).  The  concentrations
f all  bone  formation  and  reabsorption  biomarkers  (BAP,  OC,
nd S-CTx)  reduced  with  age;  the  highest  concentrations
ere observed  in  CA1  and  the  lowest  in  CA5,  which  is  the
ate phase  of  puberty  (Fig.  1  D-F).
Signiﬁcant  differences  in  weight  were  observed  between
ge groups  (CA4  and  CA5  differed  from  groups  CA1  and  CA2,
ith p  <  0.01).
Calcium  ingestion  ranged  from  489  ±  153  mg/day  to
52 ±  176  mg/day;  the  mean  ±  SD  for  the  whole  sample  was
66 ±  210  mg/day  (Table  1).
The  BMD  (lumbar  spine,  proximal  femur,  and  total  body)
nalyses showed  differences  in  groups  CA3,  CA4,  and  CA5,
hich differed  from  groups  CA1  and  CA2  with  p  <  0.01  in  all
tudy sites;  values  in  group  CA3  were  intermediate  (Fig.  1
-C).
BMD values  (lumbar  spine,  proximal  femur,  and  total
ody) differed  signiﬁcantly  between  B  (p  <  0.01).  Groups  B4
nd B5  showed  the  highest  mean  BMD  values  in  all  sites,  and
roup B3  showed  intermediate  mean  value  (Fig.  1B).
BAP,  OC,  and  S-CTx  bone  remodeling  biomarkers  had
igniﬁcantly different  concentrations  at  the  beginning  of
uberty. The  median  concentrations  in  CA1  and  CA2  were
igniﬁcantly higher  than  those  in  CA3,  CA4,  and  CA5
p <  0.001).  Median  BAP  concentrations  in  CA3  were  higher
han those  in  CA5;  in  addition,  no  signiﬁcant  difference
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Figure  1  Graphic  representation  of  bone  mass  density  (BMD)  means  and  standard  deviations  of  lumbar  spine,  proximal  femur,  and
whole  body  values  in  g/cm2 according  to  age  ranges  (A);  breast  development  stage  (B);  and  bone  age  (C).  Bone  alkaline  phosphatase
(BAP)  (D);  osteocalcin  (OC)  (E);  and  C-terminal  telopeptide  (S-CTx)  (F);  medians  according  to  age-ranges,  breast  development  stage,
and  bone-age  groups.
b
C
s
w
C
f
o
w
p
B
B
p
m
B
w
w
h
f
(
petween  CA4  and  CA5  median  concentrations  was  observed.
hanges in  OC  concentrations  according  to  age  followed  a
imilar trend  to  those  observed  for  BAP.  The  same  trend
as observed  for  S-CTx  (p  <  0.001;  Fig.  1).  The  highest  S-
Tx medians  were  observed  in  CA1  and  CA2,  which  differed
rom CA5  (Fig.  1  D-F).
Signiﬁcant differences  in  weight  and  height  were
bserved in  participants  in  BA2  and  BA1.  These  differences
ere also  observed  in  the  BA3,  BA4,  and  BA5  groups,  which
resented means  of  weight  and  height  higher  than  those  in
A1 (Table  1).
Differences in  BMD  values  were  initially  observed  in  the
A3 group,  which  differed  from  the  BA1  and  BA2  groups  with
 <  0.01  in  all  BMD  values  and  in  all  studied  sites.  The  BMD
b
t
t
aeans  increased  from  the  low  BA  groups  towards  the  high
A groups  (Fig.  1C).
Signiﬁcant differences  in  bone  remodeling  biomarkers
ere recorded  in  all  studied  variables  (BAP,  OC,  and  S-CTx)
hen presented  according  to  BA;  BA1  and  BA2  medians  were
igher than  BA4  and  BA5  medians  (Fig.  1  D-F).
A  signiﬁcant  positive  correlation  between  BMD  values,
or both  CA  and  BA,  was  observed  with  maturation  level
Table 2);  bone  remodeling  biomarkers  (BAP,  OC,  and  S-CTx)
resented a  signiﬁcant  negative  correlation  with  CA,  BA,  and
reast development  (Table  2).  This  ﬁnding  demonstrated
hat the  more  mature  the  participants  were,  the  higher
heir BMD  values  were.  Correlation  was  signiﬁcant  but  neg-
tive between  the  age  of  participants  and  bone  remodeling
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Table  2  Coeﬁcient  of  Spearman’s  correlation  between  bone  mineral  density  (BMD)  measurements  (g/cm2),  bone  biomarker
concentrations  (bone  alkaline  phosphatase,  osteocalcin,  C-  terminal  teleopeptide),  chronological  age  (CA),  Breast  development
stage  (B)  and  bone  age  (BA).
Variable  Age  and  breast  development  stage  Bone  biomarker
CA  B  BA  BAP  OC  S-CTx
BMD  (g/cm2)Spine,  L1-L4 0.754a 0.649a 0.760a -0.696a -0.367b -0.627a
Femur  0.605a 0.516a 0.652a -0.519a -0.334c -0.644a
Whole  body  0.766a 0.665a 0.789a -0.655a -0.425a -0.695a
BAP  (IU/L)  -0.822a -0.638a -0.831a -  -  -
OC (ng/ml)  -0.552a -0.602a -0.482a -  -  -
S-CTx (ng/ml)  -0.769a -0.653a -0.812a -  -  -
BAP, bone alkaline phosphatase; OC, osteocalcin; S-CTx, C-terminal teleopeptide; L1-L4, lumbar spine 1 and 4.
Signiﬁcance of Spearman’s correlation.
a p = 0.001.
b p = 0.002.
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biomarker  concentrations;  the  more  mature  the  participants
were, the  lower  their  bone  biomarker  concentrations  were
(Table 2).
Table 2  shows  the  data  from  the  coefﬁcient  of  correla-
tion analysis  between  bone  remodeling  biomarkers  and  BMD
values. These  results  demonstrate  a  negative  and  signiﬁ-
cant correlation  between  BMD  values  and  bone  biomarker
concentrations.
Discussion
The  present  study  observed  signiﬁcant  negative  correlations
between concentrations  of  bone  remodeling  biomarkers
and CA,  BA,  breast  development,  and  BMD  values.  Such
evidence reveals  inversely  proportional  outcomes  in  remod-
eling biomarkers  and  variables  that  represent  time  and  bone
mass maturation.  Thus,  although  the  BMD  values  increased
with the  advancement  of  maturation  events,  the  concentra-
tions of  the  three  biomarkers  reduced  with  age  at  the  end
of adolescence,  starting  from  15  to  16  years  of  age  (Fig.  1).
Other  authors  have  also  observed  the  lowest  bone
biomarker concentrations  at  the  end  of  puberty,  and  have
reported biomarker  concentrations  in  18-year-old  females
that are  similar  to  those  in  adults.13,21,22
Boot  et  al.8 observed  that  peak  bone  mass,  both  in  the
lumbar region  and  in  the  whole  body,  occurred  between  18
and 20  years  of  age  in  a  group  of  360  females.  Silva  et  al.23,24
and  Moretto  et  al.25 showed  that  mean  BMD  values  in  all
evaluated sites  increased  with  age,  skeletal  maturation,  and
bone age  in  Brazilian  adolescents.  In  these  studies,  the  low-
est BMD  values  were  observed  in  10-year-old  females  and
the highest  ones  in  females  aged  17  years  or  over.  The  most
critical periods  for  bone  mass  growth  were  reported  to  be
between 13  and  14  years  of  age,  in  females  at  breast  stage
B3, and  between  13  and  15  years  in  males  at  G4  stage.
These results  corroborate  the  present  ﬁndings,  suggesting
the existence  of  a  window  of  opportunity  for  bone  mass  gain,
between 13  and  14  years  of  age  and  B3,  in  the  cited  mat-
uration periods;  the  linear  regression  analyses  showed  BMD
gains of  0.0574,  0.0592,  and  0.0654  g/cm2 in  lumbar  spine,
B
h
b
iroximal  femur,  and  total  body,  respectively,  in  each  year  of
rowth in  CA.
The  literature  is  clear  and  in  agreement  that  reaching
he highest  possible  peak  bone  mass  during  adolescence  is
n important  and  possibly  the  main  preventive  factor  against
ccurrence of  senile  osteoporosis.26
The  fact  that  biomarkers  produce  sensitive  and  accurate
eadings of  changes  in  bone  metabolism  should  contribute
o their  wider  use  in  clinical  practice.  Blood  biomarker  mea-
urements can  be  repeated  more  frequently  than  the  more
ommonly used  quantitative  radiological  methods,  because
lood samples  are  comparatively  easy  to  obtain.  Despite
ifﬁculties in  the  analysis  and  interpretation  of  biomarker
esults due  to  their  biological  variability  in  the  course  of  an
ndividual’s life  time,3 there  are  advantages  in  the  use  of
hese markers.
It is  therefore  possible  to  anticipate  that,  when  indi-
iduals present  healthy  development  evolution  in  infancy
nd puberty,  free  of  conditions  that  interfere  with  bone
etabolism, bone  formation  markers  would  be  found  pro-
ortionally more  active  in  the  ﬁrst  two  decades  of  life
han reabsorption  markers.  Some  other  factors  can  affect
one remodeling  biomarker  concentrations,  such  as  genetic
actors, age,  secondary  sexual  signs  that  represent  visi-
le evolution  to  puberty,  lifestyle,  nutrition,  and  physical
xercise.27
Tuchman  et  al.22 observed  a  correlation  between  bone
iomarkers and  peak  height  velocity  (PHV),  demonstrating
 parallelism  between  increased  marker  concentrations  and
eight velocity.  Despite  this,  Harel  et  al.11 emphasized  that
he BMD  values  still  continued  to  increase  with  increasing
ge, with  a  maximum  increase  around  menarche,  which  is
hen girls  are  already  decelerating  height  velocity.  This
volution was  also  observed  in  the  present  data.  Sequen-
ially, peak  bone  mass  will  ﬁnally  be  reached  at  the  moment
hen growth  rate  in  height  reduces.  The  ﬁnal  height,  in
hese adolescents,  was  attained  when  they  reached  the  B4-
5 breast  developmental  stages.  As  previously  stated,  peak
eight velocity  (PHV)  occurs  at  the  same  time  as  the  B3
reast developmental  stage  or  a little  after  it.  This  behavior
s similar  to  that  observed  in  bone  markers  showing  the  high-
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130  
st  concentrations  in  this  developmental  stage,  reinforcing
he relationship  between  these  events  and  hormonal  fac-
ors involved  in  these  processes.  From  this  perspective,
an Coeverden  et  al.13 and  Yilmaz  et  al.6 evaluated  the
agnitude of  the  relationship  between  bone  turnover  and
eak height  velocity  (PHV)  analyzed  by  the  levels  of  some
one markers  and  evaluating  sex  steroid  levels,  insulin-like
rowth factor  (IGF-1),  and  insulin-like  growth  factor  binding
rotein 3  (IGF-BP-3).
Hence,  these  considerations  allow  for  the  understand-
ng of  high  levels  of  correlation  between  bone  biomarkers
nd bone  mineral  densities  observed  in  our  statistical
nalysis.
Yilmaz et  al.6 evaluated  91  Turkish  pubescent  females
nd 83  males,  11  to  15  years  old.  Their  inclusion  criteria,
lthough very  precise,  were  not  as  rigid  and  restrictive  as  the
resent study’s.  The  authors  evaluated  BMD  in  the  lumbar
pine and  whole  body,  as  well  as  estradiol  and  testosterone
evels, and  measured  bone  formation  markers  (OC  and  BAP)
n both  genders.  Their  results  of  maximum  increase  in  BMD
ccurring in  puberty  stage  3  corroborate  the  present  results.
hese authors  observed  that  mean  OC  concentrations  were
igher in  females  in  Tanner  stage  3  than  at  B4  or  B5  and
teadily decreased  towards  the  end  of  puberty.  This  behav-
or was  not  as  expressive  in  BAP;  however,  it  showed  that
oncentrations from  mid-puberty  were  higher  than  those
t the  end  of  puberty  with  signiﬁcant  differences  in  girls
p < 0.001).  Furthermore,  Yilmaz  et  al.6 demonstrated  signif-
cant negative  correlation  between  BMD  and  the  evaluated
one markers,  which  corroborates  the  results  observed  in
he present  study.
Longitudinal studies  performed  to  evaluate  height  veloc-
ty curve  and  maximum  concentrations  of  bone  formation
arkers could  contribute  to  conﬁrm  the  parallelism  indi-
ectly observed  between  these  variables.
Through  analyses  of  biomarkers,  the  present  study
emonstrates the  changes  in  bone  remodeling  occurring  in
he second  decade  of  life,  revealing  high  marker  concen-
rations in  the  early  adolescence  years  and  signiﬁcantly
educed concentrations  in  late  adolescence.  These  anal-
ses correlate  to  the  BMD  values,  which  represent  bone
ass incorporation,  and  indicate  an  inversely  proportional
ehavior showing  the  highest  BMD  values  associated  with
he lowest  concentrations  of  formation  and  reabsorption  of
iomarkers.
Ideally, the  present  study  should  have  had  a  longitudinal
esign including  a  higher  number  of  participants  from  a  more
omprehensive sampling  in  similar  cohorts  (schools).  Despite
his limitation,  the  strict  inclusion  criteria  favored  an  accu-
ate interpretation  of  results  for  bone  gain  and  metabolism
uring adolescence.
The results  from  the  present  study  complement  published
ork on  the  subject  and  improve  the  understanding  of  bone
ass changes  during  adolescence.unding
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